Diffuse Systemic Sclerosis with Interstitial Lung Disease and Severe Pulmonary Arterial Hypertension: A Case Report
Syed Zia Inamdar1★, Sushilkumar Londhe1, Ravina Mehta1, Sumanyu Katageri1, Siddanagouda Biradar1, Shashidhar Devaramani2, Sharan Badiger2★ Corresponding author
- 1Department of Pharmacy Practice, BLDEAs SSM College of Pharmacy and Research Centre, Vijayapura, Karnataka, INDIA.
- 2Department of Medicine, Shri B M Patil Medical College Hospital and Research Centre, Vijayapura, Karnataka, INDIA.
CORRESPONDENCE
Syed Zia Inamdar
Department of Pharmacy Practice, BLDEAs SSM College of Pharmacy and Research Centre, Vijayapura, Karnataka, INDIA.
Volume 15, Issue 4 · pp. 338–341 · PUBLISHED · DOI: 10.5530/ijopp.15.4.62
ABSTRACT
Systemic sclerosis is a rare connective tissue disease categorized by extensive lung fibrosis, vascular and immunologic abnormalities. Autoimmune antibodies like anticentromere, anti-Scl-70 (anti-topoisomerase I), and anti-RNA polymerase II are commonly involved in progressive disease. Clinical presentations consist of Raynaud’s phenomenon, digital ulcers; pericardial effusion, and telangiectasia and are mostly associated with pulmonary complications like interstitial lung disease and pulmonary arterial hypertension. Disease-specific therapy is unavailable instead; symptomatic management is only the line of treatment. We report here a case of diffuse systemic sclerosis with interstitial lung disease and pulmonary arterial hypertension.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Inamdar, S. Z., Londhe, S., Mehta, R., Katageri, S., Biradar, S., Devaramani, S., & Badiger, S. (). Diffuse Systemic Sclerosis with Interstitial Lung Disease and Severe Pulmonary Arterial Hypertension: A Case Report. Indian Journal of Pharmacy Practice, 15(4), 338–341. https://doi.org/10.5530/ijopp.15.4.62